FDA approved L-type channel blocker Nifedipine reduces cell death in hypoxic A549 cells through modulation of mitochondrial calcium and superoxide generation.


Journal

Free radical biology & medicine
ISSN: 1873-4596
Titre abrégé: Free Radic Biol Med
Pays: United States
ID NLM: 8709159

Informations de publication

Date de publication:
12 2021
Historique:
received: 26 06 2021
revised: 26 08 2021
accepted: 29 08 2021
pubmed: 20 10 2021
medline: 15 12 2021
entrez: 19 10 2021
Statut: ppublish

Résumé

As hypoxia is a major driver for the pathophysiology of COVID-19, it is crucial to characterize the hypoxic response at the cellular and molecular levels. In order to augment drug repurposing with the identification of appropriate molecular targets, investigations on therapeutics preventing hypoxic cell damage is required. In this work, we propose a hypoxia model based on alveolar lung epithelial cells line using chemical inducer, CoCl

Identifiants

pubmed: 34666149
pii: S0891-5849(21)00762-0
doi: 10.1016/j.freeradbiomed.2021.08.245
pmc: PMC8520174
pii:
doi:

Substances chimiques

Calcium Channel Blockers 0
Superoxides 11062-77-4
Nifedipine I9ZF7L6G2L
Calcium SY7Q814VUP

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

189-200

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Références

Mol Med Rep. 2019 Sep;20(3):2419-2425
pubmed: 31322172
Biochem Biophys Res Commun. 2019 Feb 26;510(1):142-148
pubmed: 30661785
J Pharm Pharmacol. 1996 Sep;48(9):906-10
pubmed: 8910851
Free Radic Biol Med. 2013 Oct;63:264-73
pubmed: 23722164
Pharmacogn Mag. 2017 Jan-Mar;13(49):7-12
pubmed: 28216876
J Thorac Oncol. 2020 May;15(5):700-704
pubmed: 32114094
Sci Rep. 2020 Jan 31;10(1):1566
pubmed: 32005874
Life Sci. 2020 Jul 15;253:117292
pubmed: 31927051
J Pineal Res. 2008 Mar;44(2):121-6
pubmed: 18289162
J Pineal Res. 2011 May;50(4):427-35
pubmed: 21362033
N Engl J Med. 2013 Jun 13;368(24):2294-302
pubmed: 23758234
PLoS One. 2013 Jul 25;8(7):e67498
pubmed: 23935835
Circ Res. 2003 Feb 7;92(2):186-94
pubmed: 12574146
Biochem Pharmacol. 2020 Jan;171:113695
pubmed: 31706846
Sci Rep. 2021 Jan 14;11(1):1462
pubmed: 33446817
Cells. 2019 Dec 30;9(1):
pubmed: 31905994
Exp Mol Med. 2019 Jul 17;51(7):1-11
pubmed: 31316050
BMJ. 2012 Jul 11;345:e4260
pubmed: 22786934
Mol Cell Biol. 2004 Aug;24(16):7130-9
pubmed: 15282312
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Monaldi Arch Chest Dis. 2020 Mar 26;90(1):
pubmed: 32236089
PLoS One. 2013 Aug 27;8(8):e72528
pubmed: 24015256
Biochem Biophys Res Commun. 1997 Jul 18;236(2):313-22
pubmed: 9240432
J Appl Toxicol. 2019 Apr;39(4):556-570
pubmed: 30484873
Cell Host Microbe. 2018 Jun 13;23(6):809-818.e5
pubmed: 29779930
Am Rev Respir Dis. 1989 Jan;139(1):120-5
pubmed: 2912331
Respir Physiol Neurobiol. 2012 Jul 31;183(1):26-34
pubmed: 22627105
Lancet Respir Med. 2021 Jun;9(6):622-642
pubmed: 33965003
Mol Cell Biochem. 2017 Dec;436(1-2):99-110
pubmed: 28589371
Am J Physiol Lung Cell Mol Physiol. 2021 Jun 1;320(6):L1186-L1193
pubmed: 33689516
Front Mol Biosci. 2020 Jul 29;7:163
pubmed: 32850957
BMC Res Notes. 2018 Apr 3;11(1):228
pubmed: 29615102
Oncol Lett. 2018 Jul;16(1):801-808
pubmed: 29971135
J Pharmacol Exp Ther. 1984 Mar;228(3):761-8
pubmed: 6707924
Molecules. 2021 Feb 15;26(4):
pubmed: 33672072
Exp Mol Med. 2019 Jul 4;51(7):1-12
pubmed: 31273199
Subcell Biochem. 2007;45:465-80
pubmed: 18193648
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Signal Transduct Target Ther. 2021 Mar 23;6(1):131
pubmed: 33758167
Sci Total Environ. 2020 Aug 25;732:139330
pubmed: 32413619
Br J Clin Pharmacol. 1988 Jun;25(6):758-60
pubmed: 3203047
Pediatr Pulmonol. 1989;6(1):53-9
pubmed: 2704584
Acta Pharmacol Sin. 2020 Dec;41(12):1539-1546
pubmed: 33110240
Int Neurourol J. 2019 Nov;23(Suppl 2):S111-118
pubmed: 31795610
Front Endocrinol (Lausanne). 2019 Nov 08;10:756
pubmed: 31781032
Proc Natl Acad Sci U S A. 1997 May 27;94(11):5667-72
pubmed: 9159130
Cell Res. 2020 Dec;30(12):1078-1087
pubmed: 33159154

Auteurs

Kuruba Manohar (K)

Department of Biotechnology, Indian Institute of Technology, Hyderabad, 502285, India.

Rishikesh Kumar Gupta (RK)

International Institute of Molecular and Cell Biology in Warsaw, Warsaw, 02 109, Poland; Postgraduate School of Molecular Medicine, Medical University of Warsaw, Warsaw, 02-091, Poland.

Parth Gupta (P)

Department of Biotechnology, Indian Institute of Technology, Hyderabad, 502285, India.

Debasmita Saha (D)

Department of Chemical Engineering, Indian Institute of Technology, Hyderabad, 502285, India.

Suman Gare (S)

Department of Chemical Engineering, Indian Institute of Technology, Hyderabad, 502285, India.

Rahuldeb Sarkar (R)

Departments of Respiratory Medicine and Critical Care, Medway NHS Foundation Trust, Gillingham, Kent, UK; Faculty of Life Sciences, King's College London, London, UK.

Ashish Misra (A)

Department of Biotechnology, Indian Institute of Technology, Hyderabad, 502285, India.

Lopamudra Giri (L)

Department of Chemical Engineering, Indian Institute of Technology, Hyderabad, 502285, India. Electronic address: giril@che.iith.ac.in.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH